McKesson agrees to buy Precision Medicine Group for $2.25 billion

Reuters2026/08/25 12:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

McKesson agreed to buy Precision Medicine Group for about USD 2.25 billion.
Business will sit in McKesson’s Oncology & Multispecialty segment once the deal closes.
Transaction aims to expand clinical research and biopharma commercialization services, including stronger clinical trial execution.
Precision Medicine Group provides clinical research and commercialization services to biopharma clients.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. McKesson Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202608250800BIZWIRE_USPR_____20260824_BW526382) on August 25, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

McKesson agrees to buy Precision Medicine Group for $2.25 billion

You may also like

Crypto prices